Willow Health Review 2026: $299/mo — Tablet = Injection, But Read This

Quick verdict

Willow's one genuinely differentiated feature: oral sublingual semaglutide at the same $299/mo as the injection — most providers treat needle-free formats as premium. The trade-offs are real: tirzepatide isn't flat (climbs to ~$524 at 15mg), only 33 states, no published cancellation terms, and a customer-service record where roughly a third of reviews are one-star.

Willow pricing — verified September 2026

Free two-day shipping, same-day prescription review, HSA/FSA accepted, cash-pay only. The $399 tirzepatide figure is a starting-dose price — budget for the maintenance dose, since 10-15mg is where trials showed the largest effect.

The needle-free pitch — and its evidence gap

Willow's oral tablet is compounded sublingual semaglutide, not Rybelsus. No published trial has tested it for weight loss, and customer reviews split cleanly: injection users report normal GLP-1 results; a recurring share of tablet users report no weight change at all. If the needle is the only barrier, that uncertainty is worth $0 in premiums — not $180/mo.

The regulatory record, precisely

• Eli Lilly lawsuit — dismissed Sept 2025: Willow was the only named defendant whose case was thrown out; Lilly couldn't show diversion from branded products
• NAD ruling Dec 2025: weight-loss and efficacy claims held unsubstantiated (Willow leaned on trials of FDA-approved products — not its own formulation)
• FTC + state AG referral: Willow initially declined to comply; claims permanently discontinued and the matter closed July 2026
• BBB-listed, not accredited; no published cancellation or refund terms — the dominant complaint themes are support delays and billing disputes

What Willow does well

• Tablet = injection pricing — unique in the category
• Flat semaglutide rate at every dose, published plainly
• No BMI threshold — markets to maintenance/lean users too (WeightCare is the other low-BMI option at BMI 20+)
• Fast intake, free 2-day shipping, HSA/FSA

The cons

• $299 is ~2.5-4x the budget floor — SnagRx $69, Pomegranate $119, Trimi $99
• Tirzepatide dose-scales to $524 — the headline $399 is starter-dose only
• ~1/3 of reviews one-star; support waits of weeks, templated replies
• 33 states only; cancellation/refund terms unpublished
• Oral tablet efficacy unproven — see above

Willow vs the needle-free field

Who should pick Willow

Good fit if you:

• Will not inject — period — and accept the oral formulation's evidence gap
• Want a flat published price and are at a stable dose
• Are in one of the 33 covered states and below a traditional BMI threshold

Skip it if you:

• Want tirzepatide at maintenance dose — $524/mo buys you brand Zepbound at $349-449
• Care about responsive support or published refund terms
• Peak Wellness Review $165-$249 Flat — 50 States, Named Pharmacy

Bottom line

Willow solves a real problem — needle phobia — with honest flat pricing, then undercuts itself with an unproven oral formulation, dose-scaled tirzepatide, and a support record that shows up in a third of its reviews. Cheaper needle-free options exist (Strut from $99), and cheaper injections everywhere else in the Price Index.

Affiliate disclosure: This article contains affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. Compounded GLP-1 medications are not FDA-approved as finished products and require a prescription. Pricing verified September 2026 — confirm at checkout.